Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

BioPlus Acquisition Corp. Create: Alert

All | News | Filings
Date FiledTypeDescription
10/06/2023 25-NSE Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities:
10/04/2023 RW Form RW - Registration Withdrawal Request:
10/04/2023 8-K Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Other Events, Financial Statement...
Docs: "Recitals",
"BioPlus Acquisition Corp. Announces Termination of Business Combination Agreement with Avertix Medical, Inc. and"
08/16/2023 425 Form 425 - Prospectuses and communications, business combinations:
08/14/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/01/2023 S-4/A Form S-4/A - Registration of securities, business combinations: [Amend]
07/17/2023 425 Form 425 - Prospectuses and communications, business combinations:
06/12/2023 SC 13D/A BioPlus Sponsor LLC reports a 34.2% stake in BioPlus Acquisition Corp.
06/12/2023 4 BioPlus Sponsor LLC (10% Owner) has filed a Form 4 on BioPlus Acquisition Corp.
Txns: Converted 5,749,999 shares @ $0
Converted 5,749,999 options to buy @ $0
06/08/2023 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION",
"Amendment to Amended and Restated Memorandum and Articles of Association",
"Promissory Note issued to BioPlus Sponsor LLC"
05/19/2023 425 Form 425 - Prospectuses and communications, business combinations:
05/19/2023 425 Form 425 - Prospectuses and communications, business combinations:
05/12/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
05/03/2023 425 Form 425 - Prospectuses and communications, business combinations:
05/03/2023 425 Form 425 - Prospectuses and communications, business combinations:
05/03/2023 8-K Quarterly results
04/27/2023 PRE 14A Form PRE 14A - Other preliminary proxy statements:
03/31/2023 10-K Annual Report for the period ended December 31, 2022
02/14/2023 SC 13G/A CANTOR FITZGERALD SECURITIES reports a 6.8% stake in BioPlus Acquisition Corp.
02/14/2023 SC 13G/A Saba Capital Management, L.P. reports a 7.6% stake in BioPlus Acquisition Corp
02/09/2023 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
02/02/2023 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
11/03/2022 10-Q Quarterly Report for the period ended September 30, 2022
11/02/2022 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
10/11/2022 8-K Other Events  Interactive Data
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION"
08/10/2022 10-Q Quarterly Report for the period ended June 30, 2022
05/12/2022 10-Q Quarterly Report for the period ended March 31, 2022
03/11/2022 10-K Annual Report for the period ended December 31, 2021
02/14/2022 SC 13G/A Saba Capital Management, L.P. reports a 6.4% stake in BioPlus Acquisition Corp
02/09/2022 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
12/17/2021 SC 13D BioPlus Sponsor LLC reports a 22.4% stake in BioPlus Acquisition Corp.
12/13/2021 8-K Quarterly results
12/13/2021 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
12/10/2021 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy